| abstract |
Novel thiazolinedione derivatives as antidiabetic agents. The present invention relates to compounds of general formula (I), their possible pharmaceutically acceptable salts and tautomeric forms. The present invention also relates to a method for obtaining and using them as antidiabetics and lipid lowering drugs, alone or in combination with other antidiabetic agents such as sulfonylureas or biguanides, as well as for the treatment of complications associated with insulin resistance, such such as hypertension, hyperuricemia or other cardiovascular, metabolic, endocrine, or other disorders related to diabetes. |